Semi-Annual Statement Of Income And Retained Earnings

KYORIN Pharmaceutical Co., Ltd. - Filing #7550544

Concept 2023-04-01 to
2023-06-30
2022-04-01 to
2022-06-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
710,000,000 JPY
489,000,000 JPY
Non-operating income
Non-operating income
253,000,000 JPY
310,000,000 JPY
Non-operating expenses
Non-operating expenses
50,000,000 JPY
20,000,000 JPY
Ordinary profit (loss)
913,000,000 JPY
779,000,000 JPY
Extraordinary income
Extraordinary income
0 JPY
879,000,000 JPY
Extraordinary losses
Extraordinary losses
1,000,000 JPY
1,000,000 JPY
Profit (loss) before income taxes
913,000,000 JPY
1,658,000,000 JPY
Profit (loss)
676,000,000 JPY
1,183,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.